Research and Markets has announced the addition of the "Western European Molecular Diagnostics Market, 2015 Forecast to 2020" report to their offering.
Across the In vitro diagnostics Segment, including research and further upcoming disruptive technologies Across the Life Sciences landscape, including research tools, clinical diagnostics and pharma, disruptive technologies transform the complete the Healthcare decision making , and diagnostics trend.
However, to take advantage of these opportunities and maintain a competitive advantage, life science companies must be able to develop a thorough holistic understanding of areas outside of their own expertise to leverage the cross-functional trends and synergistic growth opportunities that are available. Molecular diagnostics Companies who fail to capitalize on opportunities presented through emerging trends and disruptive new business models become late entrants in a market that generally before redundancy from me-too products occurs and takes market share.
This report is an elaborate structure of the European Healthcare system , which is supporting the growth of Molecular diagnostics , the reimbursement strategies and policies promoting the acceptance of MDx assays across application , This information would be suitable to understand the current need and the diagnostics style adaptation among the patient population for better outcome and clinical decision making.
Specific challenges shared in this report include shifting payment landscape (business models) who pays for services, challenge monetize Innovative Therapeutics & Molecular Diagnostics to align with Value based Care Models.
Key Topics Covered:
1. Executive Summary
2. Market Overview
3. Technology Overview
4. European Molecular Diagnostics Market Dynamics
5. Drivers and Restrains-Total Molecular Diagnostics Market
6. Forecasts and Trends-Total Molecular Diagnostics Market
7. Competitive Landscape
8. Mergers and Acquisitions
9. Molecular Diagnostics Infectious Disease Market Analysis
10. Genetic Testing Market Analysis
11. Pharmacogenomics Market Analysis
12. Oncology Market Analysis
13. Molecular Diagnostics Segment-wise Market Analysis
14. The United Kingdom Analysis
15. Germany Analysis
16. France Analysis
17. Italy Analysis
18. Spain Analysis
19. Benelux Analysis
20. Scandinavia Analysis
21. Key Participants
22. The Last Word
23. Appendix
24. CE Marked Approved Assays
For more information about this report visit http://www.researchandmarkets.com/research/h7rjh7/western_european
View source version on businesswire.com: http://www.businesswire.com/news/home/20170127005707/en/